Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization

A. Beatriz Sánchez-Heras, Adela Castillejo, Juan D. García-Díaz, Mercedes Robledo, Alexandre Teulé, Rosario Sánchez, Ángel Zúñiga, Enrique Lastra, Mercedes Durán, Gemma Llort, Carmen Yagüe, Teresa Ramon Y. Cajal, Consol López San Martin, Adrià López-Fernández, Judith Balmaña, Luis Robles, José M. Mesa-Latorre, Isabel Chirivella, María Fonfria, Raquel Perea IbañezM. Isabel Castillejo, Inés Escandell, Luis Gomez, Pere Berbel, Jose Luis Soto

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) is a very rare hereditary disorder characterized by cutaneous leiomyomas (CLMs), uterine leiomyomas (ULMs), renal cysts (RCys) and renal cell cancers (RCCs). We aimed to describe the genetics, clinical features and potential genotype-phenotype associations in the largest cohort of fumarate hydratase enzyme mutation carriers known from Spain using a multicentre, retrospective study of individuals with a genetic or clinical diagnosis of HLRCC. We collected clinical information from medical records, analysed genetic variants and looked for genotype-phenotype associations. Analyses were performed using R 3.6.0. software. We included 197 individuals: 74 index cases and 123 relatives. CLMs were diagnosed in 65% of patients, ULMs in 90% of women, RCys in 37% and RCC in 10.9%. Twenty-seven different pathogenic variants were detected, 12 (44%) of them not reported previously. Patients with missense pathogenic variants showed higher frequencies of CLMs, ULMs and RCys, than those with loss-of-function variants (p = 0.0380, p = 0.0015 and p = 0.024, respectively). This is the first report of patients with HLRCC from Spain. The frequency of RCCs was lower than those reported in the previously published series. Individuals with missense pathogenic variants had higher frequencies of CLMs, ULMs and RCys.

Original languageEnglish
Article number3277
Pages (from-to)1-16
Number of pages16
Issue number11
StatePublished - Nov 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.


  • FH gene
  • Hereditary leiomyomatosis
  • Leiomyomas
  • Missense pathogenic variants, renal cell cancer


Dive into the research topics of 'Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization'. Together they form a unique fingerprint.

Cite this